Matches in SemOpenAlex for { <https://semopenalex.org/work/W2910249384> ?p ?o ?g. }
- W2910249384 endingPage "1501" @default.
- W2910249384 startingPage "1484" @default.
- W2910249384 abstract "To address drug resistance to HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs), a series of novel diarylpyrimidine (DAPY) derivatives targeting tolerant region I and tolerant region II of the NNRTIs binding pocket (NNIBP) were designed utilizing a structure-guided scaffold-hopping strategy. The dihydrofuro[3,4- d]pyrimidine derivatives 13c2 and 13c4 proved to be exceptionally potent against a wide range of HIV-1 strains carrying single NNRTI-resistant mutations (EC50 = 0.9-8.4 nM), which were remarkably superior to that of etravirine (ETV). Meanwhile, both compounds exhibited comparable activities with ETV toward the virus with double mutations F227L+V106A and K103N+Y181C. Furthermore, the most active compound 13c2 showed favorable pharmacokinetic properties with an oral bioavailability of 30.96% and a half-life of 11.1 h, which suggested that 13c2 is worth further investigation as a novel NNRTI to circumvent drug resistance." @default.
- W2910249384 created "2019-01-25" @default.
- W2910249384 creator A5001779926 @default.
- W2910249384 creator A5005980770 @default.
- W2910249384 creator A5016741562 @default.
- W2910249384 creator A5019470503 @default.
- W2910249384 creator A5028941113 @default.
- W2910249384 creator A5034227844 @default.
- W2910249384 creator A5040662398 @default.
- W2910249384 creator A5041784391 @default.
- W2910249384 creator A5047727079 @default.
- W2910249384 creator A5049713841 @default.
- W2910249384 creator A5058817123 @default.
- W2910249384 creator A5059468550 @default.
- W2910249384 creator A5063979217 @default.
- W2910249384 creator A5067500491 @default.
- W2910249384 creator A5072097629 @default.
- W2910249384 creator A5079837566 @default.
- W2910249384 creator A5081479819 @default.
- W2910249384 creator A5086524428 @default.
- W2910249384 creator A5090316356 @default.
- W2910249384 date "2019-01-09" @default.
- W2910249384 modified "2023-10-14" @default.
- W2910249384 title "Identification of Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties" @default.
- W2910249384 cites W1493703283 @default.
- W2910249384 cites W1911648303 @default.
- W2910249384 cites W1971297095 @default.
- W2910249384 cites W1997866298 @default.
- W2910249384 cites W1999197232 @default.
- W2910249384 cites W2025718938 @default.
- W2910249384 cites W2038775337 @default.
- W2910249384 cites W2065294654 @default.
- W2910249384 cites W2080551431 @default.
- W2910249384 cites W2104966707 @default.
- W2910249384 cites W2121720236 @default.
- W2910249384 cites W2136873830 @default.
- W2910249384 cites W2319298038 @default.
- W2910249384 cites W2329944582 @default.
- W2910249384 cites W2337272231 @default.
- W2910249384 cites W2341506597 @default.
- W2910249384 cites W2517742576 @default.
- W2910249384 cites W2592342214 @default.
- W2910249384 cites W2612476106 @default.
- W2910249384 cites W2767089427 @default.
- W2910249384 cites W2884791754 @default.
- W2910249384 doi "https://doi.org/10.1021/acs.jmedchem.8b01656" @default.
- W2910249384 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7441537" @default.
- W2910249384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30624934" @default.
- W2910249384 hasPublicationYear "2019" @default.
- W2910249384 type Work @default.
- W2910249384 sameAs 2910249384 @default.
- W2910249384 citedByCount "64" @default.
- W2910249384 countsByYear W29102493842019 @default.
- W2910249384 countsByYear W29102493842020 @default.
- W2910249384 countsByYear W29102493842021 @default.
- W2910249384 countsByYear W29102493842022 @default.
- W2910249384 countsByYear W29102493842023 @default.
- W2910249384 crossrefType "journal-article" @default.
- W2910249384 hasAuthorship W2910249384A5001779926 @default.
- W2910249384 hasAuthorship W2910249384A5005980770 @default.
- W2910249384 hasAuthorship W2910249384A5016741562 @default.
- W2910249384 hasAuthorship W2910249384A5019470503 @default.
- W2910249384 hasAuthorship W2910249384A5028941113 @default.
- W2910249384 hasAuthorship W2910249384A5034227844 @default.
- W2910249384 hasAuthorship W2910249384A5040662398 @default.
- W2910249384 hasAuthorship W2910249384A5041784391 @default.
- W2910249384 hasAuthorship W2910249384A5047727079 @default.
- W2910249384 hasAuthorship W2910249384A5049713841 @default.
- W2910249384 hasAuthorship W2910249384A5058817123 @default.
- W2910249384 hasAuthorship W2910249384A5059468550 @default.
- W2910249384 hasAuthorship W2910249384A5063979217 @default.
- W2910249384 hasAuthorship W2910249384A5067500491 @default.
- W2910249384 hasAuthorship W2910249384A5072097629 @default.
- W2910249384 hasAuthorship W2910249384A5079837566 @default.
- W2910249384 hasAuthorship W2910249384A5081479819 @default.
- W2910249384 hasAuthorship W2910249384A5086524428 @default.
- W2910249384 hasAuthorship W2910249384A5090316356 @default.
- W2910249384 hasBestOaLocation W29102493842 @default.
- W2910249384 hasConcept C104317684 @default.
- W2910249384 hasConcept C112705442 @default.
- W2910249384 hasConcept C114851261 @default.
- W2910249384 hasConcept C153574943 @default.
- W2910249384 hasConcept C156719811 @default.
- W2910249384 hasConcept C159047783 @default.
- W2910249384 hasConcept C181389837 @default.
- W2910249384 hasConcept C185592680 @default.
- W2910249384 hasConcept C2776543447 @default.
- W2910249384 hasConcept C2777351918 @default.
- W2910249384 hasConcept C2779321679 @default.
- W2910249384 hasConcept C2780345285 @default.
- W2910249384 hasConcept C2909970146 @default.
- W2910249384 hasConcept C55493867 @default.
- W2910249384 hasConcept C67705224 @default.
- W2910249384 hasConcept C71240020 @default.
- W2910249384 hasConcept C86803240 @default.
- W2910249384 hasConcept C89423630 @default.
- W2910249384 hasConcept C98274493 @default.
- W2910249384 hasConceptScore W2910249384C104317684 @default.